- Home
- PRTA vs DEA Comparison
PRTA vs DEA Comparison
Compare PRTA & DEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- DEA
- Stock Information
- Founded
- PRTA 2012
- DEA 2011
- Country
- PRTA Ireland
- DEA United States
- Employees
- PRTA N/A
- DEA N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- DEA Real Estate Investment Trusts
- Sector
- PRTA Health Care
- DEA Real Estate
- Exchange
- PRTA Nasdaq
- DEA Nasdaq
- Market Cap
- PRTA 809.8M
- DEA 912.0M
- IPO Year
- PRTA N/A
- DEA 2015
- Fundamental
- Price
- PRTA $5.91
- DEA $23.01
- Analyst Decision
- PRTA Buy
- DEA Hold
- Analyst Count
- PRTA 9
- DEA 4
- Target Price
- PRTA $27.67
- DEA $27.69
- AVG Volume (30 Days)
- PRTA 2.2M
- DEA 490.2K
- Earning Date
- PRTA 08-07-2025
- DEA 07-30-2025
- Dividend Yield
- PRTA N/A
- DEA 5.48%
- EPS Growth
- PRTA N/A
- DEA N/A
- EPS
- PRTA N/A
- DEA 0.41
- Revenue
- PRTA $137,935,000.00
- DEA $314,385,000.00
- Revenue This Year
- PRTA N/A
- DEA $7.39
- Revenue Next Year
- PRTA $30.93
- DEA $8.26
- P/E Ratio
- PRTA N/A
- DEA $56.23
- Revenue Growth
- PRTA 54.55
- DEA 6.82
- 52 Week Low
- PRTA $4.32
- DEA $19.33
- 52 Week High
- PRTA $25.42
- DEA $36.31
- Technical
- Relative Strength Index (RSI)
- PRTA 46.16
- DEA 56.45
- Support Level
- PRTA $4.95
- DEA $21.54
- Resistance Level
- PRTA $6.00
- DEA $23.53
- Average True Range (ATR)
- PRTA 0.32
- DEA 0.46
- MACD
- PRTA 0.25
- DEA 0.08
- Stochastic Oscillator
- PRTA 88.59
- DEA 62.11
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
About DEA Easterly Government Properties Inc.
Easterly Government Properties Inc is a real estate investment trust. It is engaged in the acquisition, development, and management of Class A commercial properties that are leased to U.S. government agencies. The company generates all its revenue by leasing its properties to such agencies.